RegMed Forum 2027: From pluripotent stem cells (PSCs) to Next-Generation Gene and Cell Therapies - Save the Date
Human pluripotent stem cells (hPSCs) have become a key platform for regenerative medicine, enabling disease modeling, drug discovery, and the development of advanced gene- and cell-based therapies. Rapid progress in stem cell technologies is accelerating the generation, differentiation, and clinical translation of hPSC-derived products.
The RegMed Forum 2027 will showcase cutting-edge developments in hPSC-based regenerative therapies, covering novel therapeutic approaches, cell differentiation and maturation, GMP-compliant manufacturing, quality control, and regulatory aspects. Special emphasis will be placed on strategies to improve the safety, efficacy, scalability, and accessibility of next-generation therapies.
Bringing together experts from academia, start-ups, and industry, the Forum aims to promote interdisciplinary exchange on the clinical translation of advanced therapeutic approaches, including ATMPs, advanced medical devices, and combined products. The Forum seeks to encourage strategic partnerships and accelerate the translation of scientific discoveries into clinical and commercial applications. Through scientific sessions and networking opportunities, participants will explore current challenges and future opportunities in the rapidly evolving field of gene- and cell-based therapies.
An accompanying industry exhibition will provide a platform for companies and technology providers to present innovative tools, services, and therapeutic solutions.
When:
- February 11 2027 | 01:00 pm - 08:00 pm
- February 12 2027 | 09:00 am - 02:00 pm
Industry Exhibition
Are you interested in participating in our industry exhibition at the upcoming RegMed Forum on 11-12 February 2027? For further information, please contact Anne-Christin Schöne.
Agenda Day 1 - February, 11
Registration with Welcome Coffee
Welcome and Introduction
Ludovic Vallier (Berlin Institute of Health – Center for Regenerative Therapies, Max Planck Institute for Molecular Genetics)
Daniel Besser (German Stem Cell Network (GSCN) e.V.)
Jasmin Podufall (Berlin Partner)
Session 1
Moderator: Ludovic Vallier (Berlin Institute of Health)
Wolfram-Hubertus Zimmermann
Department of Pharmacology and Toxicology University Medical Center Goettingen
Daniel Ortmann
Berlin Institute of Health – Center for Regenerative Therapies
Barbara Ludwig
Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Fakultät Dresden, TU Dresden
Alexander Leutner (tbc)
Cellbricks
Coffee break
Session 2
Moderator: Harald Stachelscheid (Berlin Institute of Health)
Panel - What are the challenges involved in developing human pluripotent stem cell therapies in Germany?
Moderation Panel: Christopher Baum (Berlin Institute of Health)
Wolfram-Hubertus Zimmermann (Department of Pharmacology and Toxicology University Medical Center Goettingen)
Françoise Carlotti (Leiden University Medical Center)
Annette Künkele-Langer (Charité - Universitätsklinikum Berlin)
Andreas Scheel
Evotec
Eric Metzler-Bräuchle
MyoPax
Robert Zweigerdt
Medizinische Hochschule Hannover
Networking with Dinner and Industry exhibition
End of Day 1
Agenda Day 2 - February, 12
Registration with Welcome Coffee
Session 3
Moderator: Leila Amini
Ludovic Vallier
Greg Motz
Bluerock
Boris Greber
Catalent Pharma Solutions
Françoise Carlotti
Leiden University Medical Center
Fabian Bachinger
Berlin Institute of Health – Center for Regenerative Therapies
Coffee break
Session 4
Moderator: Daniel Besser (German Stem Cell Network (GSCN) e.V.)
Malin Parmar (tbc)
Developmental and Regenerative Neurobiology, University Lund
Sarah Eminli-Meissner (tbc)
REPROCELL
Olaf Strauß
Charité – Universitätsklinik Berlin
Sebastian Knöbel
Miltenyi
Closing Words
Ludovic Vallier (Berlin Institute of Health – Center for Regenerative Therapies, Max Planck Institute for Molecular Genetics)
Daniel Besser (German Stem Cell Network (GSCN) e.V.)
Jasmin Podufall (Berlin Partner)
End of Day 2
What to expect?
- Talks & panel discussions with different stakeholders.
- Onsite networking opportunity.
- Industry exhibition to present your products and services
You should attend if you...
- Develop or manufacture innovative therapeutic approaches
- Provide services or products that support the field of therapy development, manufacturing and translation
- Want to learn about academic vs. industrial settings for therapy development
- Expand your knowledge about clinical trials innovative products
- Explore new partnership opportunities for your institution
- Wish to expand your professional network
Who will be attending?
Academic researchers, manufacturers, pharma companies and spin-offs/start-ups interested in clinical translation of innovative therapies.
Registration:
- Participation fee: 50,00 €
- Student participation fee: 20,00 €
For more information please click here.
This event is organized by the BIH Center for Regenerative Therapies at Charité, Berlin Partner, HealthCapital Berlin-Brandenburg, as well as the German Stem Cell Network (GSCN) e.V.
